REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Energenesis Biomedical CO.,Ltd. (Taiwan, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Energenesis Biomedical CO.,Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Energenesis Biomedical Co., Ltd. is engaged in the research and development of biotechnology drugs. The company was founded in 2012 and is headquartered in Taipei City, Taiwan.

Headquarters
6F.-3, No.21, Ln.583, Ruiguang Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Energenesis Biomedical CO.,Ltd. report to view the information.

Website: http://www.energenesis-biomedical.com

Basic Information
Total Employees:
Purchase the Energenesis Biomedical CO.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Energenesis Biomedical CO.,Ltd. report to view the information.
Financial Auditors:
Purchase the Energenesis Biomedical CO.,Ltd. report to view the information.
Incorporation Date:
August 28, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
8.3%
Purchase this report to view the information.
5.55%
Purchase this report to view the information.
0.11%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Energenesis Biomedical CO.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-11.12%▼
Total operating revenue
-8.69%▼
Operating profit (EBIT)
30.16%▲
EBITDA
30.73%▲
Net Profit (Loss) for the Period
40.15%▲
Total assets
-20.65%▼
Total equity
-19.77%▼
Operating Profit Margin (ROS)
975.93%▲
Net Profit Margin
1460.9%▲
Return on Equity (ROE)
4.29%▲
Quick Ratio
7.04%▲
Cash Ratio
2.32%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo